XPONANCE, INC. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$224,783
-16.7%
14,164
-0.9%
0.00%
-25.0%
Q2 2023$269,690
+472.6%
14,292
+16.5%
0.00%
+300.0%
Q1 2023$47,098
-22.6%
12,2650.0%0.00%0.0%
Q4 2022$60,834
+4.9%
12,265
+1.5%
0.00%0.0%
Q3 2022$58,000
+11.5%
12,080
+4.2%
0.00%0.0%
Q2 2022$52,000
+6.1%
11,594
+13.5%
0.00%0.0%
Q1 2022$49,000
-29.0%
10,216
-2.6%
0.00%0.0%
Q2 2021$69,00010,4940.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders